The IRMA Community
Newsletters
Research IRM
Click a keyword to search titles using our InfoSci-OnDemand powered search:
|
The Genus Origanum: Secondary Metabolites, Therapeutic Properties, and Traditional Uses
|
|
Author(s): Mustafa Eray Bozyel (Dokuz Eylül University, Turkey), Elif Merdamert-Bozyel (Health Institutes of Türkiye, Turkey), Cenker Yaman (Graduate School of Natural and Applied Sciences, Dokuz Eylül University, Turkey), Gizem Gül (Dokuz Eylül University, Turkey), Selime Deniz Bozkurt (Dokuz Eylül University, Turkey)and Kerem Canlı (Dokuz Eylül University, Turkey)
Copyright: 2025
Pages: 60
Source title:
Secondary Metabolites and Their Applications in Various Diseases
Source Author(s)/Editor(s): Athanasios Alexiou (Novel Global Community Education Foundation, Australia), Saurabh Kumar Jha (Department of Zoology, Kalindi College, University of Delhi, India)and Roma Pandey (Department of Biotechnology, IILM University, Greater Noida, India)
DOI: 10.4018/979-8-3693-9112-9.ch012
Purchase
|
Abstract
The genus Origanum (Lamiaceae) encompasses a variety of species recognized for their medicinal properties. It has a wide distribution in the Northern Hemisphere, particularly in the Mediterranean Basin. The term “oregano” is used to refer to several species within the genus Origanum. Origanum species have been used in traditional medicinal practices since ancient times to treat various ailments. Secondary metabolites produced by this genus are important as they take an active role in numerous therapeutic properties and biological activities, including antibacterial, antifungal, antiviral, antioxidant, anti-inflammatory, and antitumor effects. The most prevalent secondary metabolites in this genus are carvacrol, thymol, gamma-terpinene, p-cymene, and linalool. These secondary metabolites play an important role in the therapeutic properties and biological activities of the genus. This study aims to present a comprehensive review of the traditional uses of the genus Origanum, its secondary metabolites, and their therapeutic properties.
Related Content
|
Yiannis Koumpouros.
© 2026.
36 pages.
|
|
Antonios Archontis, Yiannis Koumpouros.
© 2026.
48 pages.
|
|
R Velmurugan, J Sudarvel, Ravi Thirumalaisamy.
© 2026.
24 pages.
|
|
S. Ida Evangeline.
© 2026.
20 pages.
|
|
Ramya Raghavan, Srusti Shankar Moger, SaiMahima Umesh, G N Bhuvana.
© 2026.
36 pages.
|
|
Tiago Manuel Horta Reis da Silva.
© 2026.
32 pages.
|
|
Tiago Manuel Horta Reis da Silva.
© 2026.
32 pages.
|
|
|